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Abstract
Concern over consistency and completeness of surgical site infection (SSI) surveillance has
increased due to public reporting of hospital SSI rates and imminent non-payment rules for
hospitals that do not meet national benchmarks. 1 Already, hospitals no longer receive additional
payment from the Centers for Medicare & Medicaid Services (CMS) for certain infections
following coronary artery bypass graft (CABG) surgery, orthopedic procedures, and bariatric
surgery.2
One major concern is incomplete and differential post-discharge surveillance. At present,
substantial variation exists in how and whether hospitals identify SSI events after the
hospitalization in which the surgery occurred. Parameters used for SSI surveillance such as the
duration of the window of time that surveillance takes place following the surgical procedure can
impact the completeness of surveillance data. Determination of the optimal surveillance time
period involves balancing the potential increased case ascertainment associated with a longer
follow-up period with the increased resources that would be required. Currently, the time window
for identifying potentially preventable SSIs related to events at the time of surgery is not fully
standardized. The Centers for Disease Control and Prevention (CDC) National Healthcare
Surveillance Network (NHSN) requires a 365-day postoperative surveillance period for
procedures involving implants and a 30-day period for non-implant procedures. 3 In contrast, the
National Surgical Quality Improvement Program (NSQIP) and the Society of Thoracic Surgeons
(STS) systems employ 30-day post-operative surveillance regardless of implant. As consensus
builds towards national quality measures for hospital-specific SSI rates, it will be important to
assess the frequency of events beyond the 30-day post-surgical window that may quantify the
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value of various durations of surveillance, and ultimately inform the choice of specific outcome
measures.
We evaluated the fraction of deep and organ/space SSIs detected beyond 30 days following
CABG, orthopedic procedures, and mastectomy with implant surgical procedures to inform
whether a longer SSI surveillance time period identifies sufficient additional SSI cases to
warrant additional surveillance resources.
SSIs were identified as part of retrospective cohort studies at five hospitals following total
hip replacements (THRs) and total knee replacements (TKRs) performed from January 1,
2007 – December 31, 2007.4 SSIs with onset of infection within 365 days of surgery were
identified by: a) routine surveillance by hospital infection prevention programs, which was
not standardized and commonly involved a combination of review of microbiology records
and evaluation of readmissions or reoperations that came to attention, and b) cases flagged
by a previously-validated algorithm involving antibiotic data, administrative diagnostic
codes, and readmission criteria.5
Previously-identified post-CABG SSIs were identified from a 2005 retrospective cohort
study of Medicare beneficiaries undergoing CABG in US hospitals ranked in the top and
bottom deciles based upon case mix–adjusted probabilities of an SSI-related claim code
within 60 days of surgery. The Romano score was used for case mix adjustment, and was
demonstrated as a significant predictor of SSI. 6 Randomly selected medical records were
reviewed for SSI.
Lastly, we evaluated previously identified SSI cases following mastectomy procedures
involving implantation of prosthetic material from an academic medical center (August
2005–December 2007). Data were collected from the surgical admission, readmissions and
clinic visits within one year of surgery. 7
All SSIs were limited to those involving deep incisional (DI) or organ/space (OS) infections.
Time from surgery to SSI onset was calculated for all SSIs and grouped into ≤30 days and
31–60 days for CABG, while TKR, THR and mastectomy procedures included additional
groupings of 61–90 days, and 91–365 days.
We identified 27 SSIs following 1,666 TKRs, 21 SSIs following 1,691 THRs, 477 SSI
following 23,376 CABGs, and 54 SSIs following 327 mastectomies with implants (Figure
1). Based upon these identified SSIs, TKR required 60 days to identify the majority of
cases.8 By 90 days post-procedure, 100% of known DI/OS SSIs were identified for THR,
70% of DI/OS SSIs for TKR, and 87% of DI/OS SSIs for mastectomy with implants.
Limiting post-operative SSI surveillance to 30-days would lead to under-reporting of
approximately one quarter to two thirds of DI/OS SSIs across the four procedures surveyed.
Confining post-operative SSI surveillance to 60 days, as was done for all CABG procedures,
results in detection of the vast majority of DI/OS SSIs following THR and mastectomy-plus-
implant procedures, but only half of DI/OS SSIs following TKR. In contrast, a 90-day
window detected most DI/OS SSIs across these three procedures. A limitation of all SSI
estimates across THR, TKR and mastectomy-plus-implant procedures was that follow-up
was confined to the hospital where the index procedure was performed. Therefore, results
represent minimum estimates of infection since post-discharge outpatient events and SSIs
identified at other hospitals were not captured. In contrast, the use of insurer claims to
identify CABG SSIs regardless of the location of medical care would allow for more
confidence that all medically attended DI/OS infections were captured.6
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Impending CMS SSI surveillance measures for mandatory reporting should consider
including DI/OS SSI surveillance periods for TKR, THR, CABG and mastectomy-plus-
implant procedures beyond 30 days. Nevertheless, additional research is needed to assess
whether resources to extend surveillance out to 365 days post-procedures is prudent given
limited resources, the fact that most DI/OS SSIs are captured within 90 days, and the
uncertainty whether SSIs occurring that long after surgery are in fact due to preventable
issues at the time of the operation.
Regardless of which duration of post-discharge surveillance is selected, assurance that
hospitals are conducting post-discharge surveillance using standardized methods is
necessary for inter-hospital comparison. Training and validation to ensure similarly
comprehensive SSI capture across hospitals is critical for valid public reporting used to
determine Medicare payment. In addition, comparison and improvement of existing case
mix adjustors should be performed to properly account for different patient population risks
for SSI. Early successful explorations into the use of large networks of claims-based
databases appear promising in this regard since both case mix adjustment and claims-based
algorithms to trigger chart review have been shown to be superior to routine surveillance
performed by hospital infection prevention programs for SSI detection and can be used to
standardize post-discharge SSI surveillance. 6, 9, 10
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Distribution of time to onset of Deep-incisional (DI) and Organ space (OS) surgical site
infections (SSIs) following total knee replacement (TKR), total hip replacement (THR),
mastectomy with implant reconstruction, and coronary artery bypass grafting (CABG)
surgeries. Duration of post-procedure follow-up for DI/OS SSI was 365 days for TKR, THR
and Mastectomy with implant, and 60 days for CABG.
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